by investoropportunity | Sep 22, 2024 | Company Research, Energy, Home Page Feature Articles, Mining, Technology
A world class hydrogen asset in the making. The level of interest from large industry players now following QI Materials’ hydrogen exploration efforts is significant. Chances are QIMC will not exist in a year or so as with every positive news release it increasingly...
by investoropportunity | Apr 30, 2024 | Company Research, Home Page Feature Articles
According to the Centers for Medicare and Medicaid Services, Americans spent $4.4 trillion on healthcare in 2022, ~$3 trillion of this spending flowed through health insurance companies. Healthcare spending is forecast to top $7 trillion in 2031. What makes Oscar...
by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Feature Articles, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
by investoropportunity | Nov 18, 2022 | Company Research, Health, Home Page Articles of Insight, Technology
Vicarious Surgical Robotic System was added to Time Magazine’s list for the ‘Best Inventions of 2022’ — for reference; Apple’s iPhone was featured by Time in 2007 Best Inventions — NYSE: RBOT has moon-shot potential. Vicarious Surgical...
by investoropportunity | Sep 26, 2022 | Company Research, Energy, Home Page Articles of Insight, Industry & Services, Technology, Uncategorized, Utilities Telecom Networks
NuScale’s VOYGR Power Module which can generate up to 77 MW, the smallest light water reactors in the world. A client can add modules over time as power needs grow. The current market-cap relative to potential market appears undervalued. NuScale Power (SMR)...
by investoropportunity | Sep 23, 2022 | Basic Materials, Company Research, Home Page Articles of Insight, Mining, Uncategorized
Best-of-breed fertilizer stock — Nutrien is looking at sales of ~$40 B this 2022 (43.6% higher than in 2021), profit should excel; in Q2-2022 Nutrien produced nearly as much free cash flow as it did in all of 2021. Looking for exposure to a hot commodity sector...
Recent Comments